![](https://endpts.com/wp-content/uploads/2021/01/Ron-Cohen-Acorda-tile-scaled.jpg)
Ron Cohen, Acorda Therapeutics president & CEO
Letters to the Editor: Don't expect a correlation between an individual drug's development cost and price
Endpoints News recently reported on a new paper in JAMA that purports to show that there is no correlation between the price of a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.